Anti-Retroviral Drugs Market Size and Growth Rate:

“The Global Anti-Retroviral Drugs Market was valued around US$ XX Mn by 2018 and growing at a significant CAGR of 7.4% over next seven years 2019-2025 owing to rising prevalence of HIV”

Anti-Retroviral Drugs Market Growth Drivers and Restraints:

Some of the key factors favouring the market growth are increasing viral diseases, rising prevalence of HIV and increase in availability of novel drugs with better efficacy. However, factors such as stringent regulatory policies required in drug approval stages and side effects caused by antiretroviral drugs are hampering the market growth. In addition, launch of new products by major market players is expected to be one of the major trend during the forecast period.

Browse More Details of the report @ https://www.precisionbusinessinsights.com/market-reports/global-antiretroviral-drugs-market/

Protease Inhibitors Dominate the Global Anti-Retroviral Drugs Market

Based on drug class, global Anti-Retroviral Drugs market segmented into nucleoside reverse transcriptase inhibitors (NRT’s), non- nucleoside reverse transcriptase inhibitors (NNRT’s), protease inhibitors, integrate inhibitors, fusion inhibitors, chemokine receptor inhibitors and others. Protease Inhibitors segment held considerable market growth during estimated period. Protease inhibitors (PIs) are a class of antiviral drugs that are widely used to treat HIV/AIDS and hepatitis C. Protease inhibitors prevent viral replication by selectively binding to viral proteases (e.g. HIV-1 protease) and blocking proteolytic cleavage of protein precursors that are necessary for the production of infectious viral particles. Protease inhibitors can decrease HIV to undetectable levels in the body.

North America Leads the Global Anti-Retroviral Drugs market

PBI’s global Anti-Retroviral Drugs market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis. This region is one of the key markets for Anti-Retroviral Drugs. The region has witnessed considerable growth in this market due to high ART coverage rate and more emphasis towards prescribed branded drugs. In addition, Asia Pacific is expected to witness considerable growth in the market owing to the support provided by various government organizations regarding awareness of retroviral diseases especially HIV/AIDS coupled with rapidly developing healthcare infrastructure.

Strategic New product Launch are the Key Strategies Adopted by Market Players

Global Anti-Retroviral Drugs market further reveals that the key players increasingly adopting strategies such as launch of newer products, frequent product approvals, and long term alliance to improve market revenue share and gaining significant geographic presence across the region. For Instance, in 2018, Mylan N.V. launched two new HIV treatments, Symfi Lo™ and Cimduo™. These launches will extend Mylan's global antiretroviral (ARV) platform and help address the high cost of HIV treatment in the U.S.

Key player’s profiles in the report are GlaxoSmithKline Plc (U.K.), Abbott Laboratories (U.S.), AstraZeneca plc (U.K.), Modified Polymer Components, Inc. (Bristol-Myers-Squibb) (U.S), Gilead Sciences (U.S.), and F. Hoffmann-La Roche AG (Switzerland).

Avail Sample of the report @ https://www.precisionbusinessinsights.com/request-sample?product_id=15527

Detailed Segmentation of Anti-Retroviral Drugs Market:

By Route of Administration
o Oral
o Parenteral

By Distribution Channel
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
o Others

By Drug Class
o Nucleoside Reverse Transcriptase Inhibitors (NRT’s)
o Non- Nucleoside Reverse Transcriptase Inhibitors (NNRT’s)
o Protease Inhibitors
o Integrate Inhibitors
o Fusion Inhibitors
o Chemokine Receptor Inhibitors
o Others

By Geography
o North America
o Europe
o Asia-Pacific
o Latin America
o Middle East and Africa (MEA)

About Us:

Precision Business Insights is one of the leading market research and management consulting firm, run by a group of seasoned and highly dynamic market research professionals with a strong zeal to offer high-quality insights.

Contact Us:

Shreya Paul
Senior Business Development Executive
Email @ [email protected]
Call @ +1-866-598-1553
Precision Business Insights